Obstet Gynecol Sci.  2015 Nov;58(6):542-546. 10.5468/ogs.2015.58.6.542.

Three cases of complications after high-intensity focused ultrasound treatment in unmarried women

• Kim HK
• Kim D
• Lee MK
• Lee CR
• Kang SY
• Chung YJ
• Cho HH
• Kim JH
• Kim MR

• KMID: 2314076
• DOI: http://doi.org/10.5468/ogs.2015.58.6.542

Abstract

High-intensity focused ultrasound (HIFU) has been regarded as a non-surgical, minimally invasive therapeutic option for patients who prioritize uterus-conservation. Although many studies have shown that HIFU therapy is a safe and effective treatment of uterine fibroid, not all fibroids are suitable for HIFU due to risks of serious complications. We experienced three cases of complications after the HIFU ablation for huge uterine fibroids, including two cases of rapid myoma enlargement and one case of heavy vaginal bleeding.

Keyword

Complications; High-intensity focused ultrasound; Leiomyoma

MeSH Terms

Female
Humans
Leiomyoma
Myoma
Single Person*
Ultrasonography*
Uterine Hemorrhage

Figure

• 

  Fig. 1 (A) Huge uterine fibroid with degenerative change in T2-weighted image after 12 times of high-intensity focused ultrasound. (B) Degenerated uterine myoma after myomectomy.

• 

  Fig. 2 (A) T2-weighted magnetic resonance image of 5.5-cm-sized submucosal myoma before high-intensity focused ultrasound. (B) 6.1-cm-sized myoma with focal degeneration after ten months of high-intensity focused ultrasound.

• 

  Fig. 3 (A) T2-weighted image after 2 years of high-intensity focused ultrasound. (B) 16-cm-sized degenerated myoma after myomectomy. (C) Removed variable-sized other nine myomas including a 6-cm-sized subserosal myoma.

Reference

1. Gorny KR, Woodrum DA, Brown DL, Henrichsen TL, Weaver AL, Amrami KK, et al. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol. 2011; 22:857–864.

2. Parker WH. Uterine fibroid. In : Berek JS, editor. Berek & Novak's gynecology. 15th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2012. p. 464.

3. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 1990; 97:285–298.

4. Mahmoud MZ, Alkhorayef M, Alzimami KS, Aljuhani MS, Sulieman A. High-Intensity Focused Ultrasound (HIFU) in uterine fibroid treatment: review study. Pol J Radiol. 2014; 79:384–390.

5. Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2011; 2:8–27.

6. Bohlmann MK, Hoellen F, Hunold P, David M. High-Intensity focused ultrasound ablation of uterine fibroids: potential impact on fertility and pregnancy outcome. Geburtshilfe Frauenheilkd. 2014; 74:139–145.

7. Zhang L, Zhang W, Orsi F, Chen W, Wang Z. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: a review of safety and efficacy. Int J Hyperthermia. 2015; 31:280–284.

8. Quinn SD, Vedelago J, Gedroyc W, Regan L. Safety and five-year re-intervention following magnetic resonanceguided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014; 182:247–251.

9. Behera MA, Leong M, Johnson L, Brown H. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril. 2010; 94:1864–1868.

10. O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009; 25:14–25.

11. Froling V, Kroncke TJ, Schreiter NF, Scheurig-Muenkler C, Collettini F, Hamm B, et al. Technical eligibility for treatment of magnetic resonance-guided focused ultrasound surgery. Cardiovasc Intervent Radiol. 2014; 37:445–450.